Vuong Trieu, CHAIRMAN AND CEO, 10% Owner at Oncotelic Therapeutics, Inc. (OTLC), bought 346,844 shares at $0.03 ($10K) on 2025-01-31, disclosed to the SEC on 2025-01-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.03 | 183,066 | $5K | 52.8% |
| 2 | $0.03 | 100,003 | $3K | 28.8% |
| 3 | $0.03 | 63,775 | $2K | 18.4% |
| Total | $0.03 avg | 346,844 | $10K | 100% |
| Filing → |
| OTLC | BUY | 2026-06-17 | $15K | — | Filing → |
| OTLC | BUY | 2025-07-10 | $2K | — | Filing → |
| OTLC | BUY | 2024-11-26 | $9K | — | Filing → |